About: Heptavalent botulism antitoxin

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Heptavalent botulism antitoxin Goto Sponge NotDistinct Permalink

An Entity of Type : yago:Unit109465459, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon

http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FHeptavalent_botulism_antitoxin&invfp=IFP_OFF&sas=SAME_AS_OFF

The Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine) – BAT, made by Emergent BioSolutions Canada Inc. (formerly Cangene Corporation) – is a licensed, commercially available botulism anti-toxin that effectively neutralizes all seven known botulinum nerve toxin serotypes (types A, B, C, D, E, F and G). It is indicated for sporadic cases of life-threatening botulism and is also stockpiled for the eventuality of botulinum nerve toxins being used in a future bioterrorist attack.

Attributes	Values
rdf:type	yago:WikicatAntitoxins yago:WikicatMedicalTreatments yago:Abstraction100002137 yago:Act100030358 yago:Activity100407535 yago:Antibody115027189 yago:Antitoxin115028050 yago:Care100654885 yago:Chemical114806838 yago:Compound114818238 yago:Event100029378 yago:Macromolecule114944888 yago:Material114580897 yago:Matter100020827 yago:Molecule114682133 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Protein114728724 yago:PsychologicalFeature100023100 yago:Relation100031921 yago:Work100575741 yago:YagoPermanentlyLocatedEntity yago:Substance100019613 yago:Thing100002452 yago:Treatment100658082 yago:Unit109465459
rdfs:label	Heptavalent Botulism Antitoxin (de) Heptavalent botulism antitoxin (en)
rdfs:comment	Das Heptavalent Botulism Antitoxin (H-BAT, Eigenschreibweise des Herstellers Cangene: Heptavalent Botulism AntiToxin) ist eine Mischung von sieben verschiedenen Antikörpern, die zur Behandlung von Botulismus verwendet werden. (de) The Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine) – BAT, made by Emergent BioSolutions Canada Inc. (formerly Cangene Corporation) – is a licensed, commercially available botulism anti-toxin that effectively neutralizes all seven known botulinum nerve toxin serotypes (types A, B, C, D, E, F and G). It is indicated for sporadic cases of life-threatening botulism and is also stockpiled for the eventuality of botulinum nerve toxins being used in a future bioterrorist attack. (en)
dcterms:subject	Immunology Antitoxins Biological warfare Botulism Immune system Medical treatments
Wikipage page ID	39186685 (xsd:integer)
Wikipage revision ID	1106219566 (xsd:integer)
Link from a Wikipage to another Wikipage	Cangene Public Health Agency of Canada Medical equipment Botulinum toxin Botulism Department of Health and Human Services Antitoxin Investigational New Drug Immunology Antitoxins Emergent BioSolutions Passive immunity Biological warfare Centers for Disease Control and Prevention Botulism Food and Drug Administration Fragment antigen-binding Fragment crystallizable region Immune system Medical treatments Biomedical Advanced Research and Development Authority Office of the Assistant Secretary for Preparedness and Response Strategic National Stockpile Canadian Department of National Defense IgG antibodies Anti-toxin Bioterrorist Botulinum U.S. Army Medical Research Institute of Infectious Diseases dbr:Bivalent_botulinum_antitoxin_AB dbr:Monovalent_botulinum_antitoxin_E dbr:Trivalent_botulinum_antitoxin
Link from a Wikipage to an external page	https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5910a4.htm https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345128.htm
sameAs	Heptavalent botulism antitoxin Heptavalent botulism antitoxin Heptavalent botulism antitoxin Heptavalent botulism antitoxin Heptavalent botulism antitoxin
dbp:wikiPageUsesTemplate	dbt:Citation_needed dbt:Reflist dbt:Snd dbt:Use_mdy_dates
has abstract	Das Heptavalent Botulism Antitoxin (H-BAT, Eigenschreibweise des Herstellers Cangene: Heptavalent Botulism AntiToxin) ist eine Mischung von sieben verschiedenen Antikörpern, die zur Behandlung von Botulismus verwendet werden. (de) The Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine) – BAT, made by Emergent BioSolutions Canada Inc. (formerly Cangene Corporation) – is a licensed, commercially available botulism anti-toxin that effectively neutralizes all seven known botulinum nerve toxin serotypes (types A, B, C, D, E, F and G). It is indicated for sporadic cases of life-threatening botulism and is also stockpiled for the eventuality of botulinum nerve toxins being used in a future bioterrorist attack. BAT was first approved in 2010 by the Centers for Disease Control for the indication of treating naturally occurring non-infant botulism on an investigational basis, replacing two earlier products. It was then licensed for commercial marketing by the United States FDA in 2013. (en)
prov:wasDerivedFrom	wikipedia-en:Heptavalent_botulism_antitoxin?oldid=1106219566&ns=0
page length (characters) of wiki page	15722 (xsd:nonNegativeInteger)
foaf:isPrimaryTopicOf	wikipedia-en:Heptavalent_botulism_antitoxin
is Link from a Wikipage to another Wikipage of	Cangene Botulinum toxin Botulism Index of immunology articles Health Canada HBAT
is Wikipage redirect of	HBAT
is foaf:primaryTopic of	wikipedia-en:Heptavalent_botulism_antitoxin

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 60 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software